KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Emergent BioSolutions (EBS) Return on Sales: 2010-2024

Historic Return on Sales for Emergent BioSolutions (EBS) over the last 15 years, with Dec 2024 value amounting to -0.18%.

  • Emergent BioSolutions' Return on Sales rose 32.00% to 0.10% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.10%, marking a year-over-year increase of 32.00%. This contributed to the annual value of -0.18% for FY2024, which is 54.00% up from last year.
  • Per Emergent BioSolutions' latest filing, its Return on Sales stood at -0.18% for FY2024, which was up 74.80% from -0.72% recorded in FY2023.
  • Emergent BioSolutions' Return on Sales' 5-year high stood at 0.19% during FY2020, with a 5-year trough of -0.72% in FY2023.
  • Its 3-year average for Return on Sales is -0.37%, with a median of -0.19% in 2022.
  • In the last 5 years, Emergent BioSolutions' Return on Sales plummeted by 54bps in 2023 and then surged by 54bps in 2024.
  • Yearly analysis of 5 years shows Emergent BioSolutions' Return on Sales stood at 0.19% in 2020, then decreased by 7bps to 0.12% in 2021, then slumped by 31bps to -0.19% in 2022, then tumbled by 54bps to -0.72% in 2023, then surged by 54bps to -0.18% in 2024.